These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15222976)

  • 1. An RNA external guide sequence ribozyme targeting human interleukin-4 receptor alpha mRNA.
    Dreyfus DH; Matczuk A; Fuleihan R
    Int Immunopharmacol; 2004 Aug; 4(8):1015-27. PubMed ID: 15222976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
    Scherr M; LeBon J; Castanotto D; Cunliffe HE; Meltzer PS; Ganser A; Riggs AD; Rossi JJ
    Mol Ther; 2001 Nov; 4(5):454-60. PubMed ID: 11708882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro selection of external guide sequences for directing human RNase P to cleave a target mRNA.
    Raj S; Liu F
    Methods Mol Biol; 2004; 252():413-24. PubMed ID: 15017067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of bacterial RNase P RNA as a drug target.
    Willkomm DK; Gruegelsiepe H; Goudinakis O; Kretschmer-Kazemi Far R; Bald R; Erdmann VA; Hartmann RK
    Chembiochem; 2003 Oct; 4(10):1041-8. PubMed ID: 14523922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
    Hayashidani Y; Hiyama E; Murakami Y; Sueda T
    Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNase P-mediated inhibition of viral growth by exogenous administration of short oligonucleotide external guide sequence.
    Dunn W; Liu F
    Methods Mol Biol; 2004; 252():425-36. PubMed ID: 15017068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General design and construction of RNase P ribozymes for gene-targeting applications.
    Zou H; Chan K; Trang P; Liu F
    Methods Mol Biol; 2004; 252():385-98. PubMed ID: 15017065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing RNase P ribozymes for gene-targeting and antiviral therapy.
    Trang P; Kim K; Liu F
    Cell Microbiol; 2004 Jun; 6(6):499-508. PubMed ID: 15104592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of gene expression by targeted disruption of messenger RNA: available options and current strategies.
    Jen KY; Gewirtz AM
    Stem Cells; 2000; 18(5):307-19. PubMed ID: 11007915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and expression of chimeric U1/ribozyme transgenes.
    Abounader R; Montgomery R; Dietz H; Laterra J
    Methods Mol Biol; 2004; 252():209-19. PubMed ID: 15017051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel integrated strategy (full length gene targeting) for mRNA accessible site tagging combined with microarray hybridization/RNase H cleavage to screen effective antisense oligonucleotides.
    Sun Y; Duan M; Lin R; Wang D; Li C; Bo X; Wang S
    Mol Vis; 2006 Nov; 12():1364-71. PubMed ID: 17149362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific gene delivery using RNA-targeting Tetrahymena group I intron.
    Jung HS; Kwon BS; Lee SW
    Biotechnol Lett; 2005 Apr; 27(8):567-74. PubMed ID: 15973491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the regions of RNase P catalytic RNA that are potentially in close contact with its protein cofactor.
    Trang P; Liu F
    Methods Mol Biol; 2008; 488():267-77. PubMed ID: 18982298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-4 receptor signaling pathways in asthma pathogenesis.
    Chatila TA
    Trends Mol Med; 2004 Oct; 10(10):493-9. PubMed ID: 15464449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the expression of the human RNase P protein subunits Rpp21, Rpp25, Rpp29 by external guide sequences (EGSs) and siRNA.
    Zhang H; Altman S
    J Mol Biol; 2004 Sep; 342(4):1077-83. PubMed ID: 15351636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constructing the eukaryotic expression vector to study preliminarily the functions of hammerhead ribozyme targeting base excision repair gene HOGG1.
    Zhang ZZ; Zhang Q; Wu M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):165-70. PubMed ID: 16608066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and structure of interleukin 4 receptor (IL-4R) complex in human invasive pituitary adenomas.
    Chen L; Liu Y; Hou Y; Kato Y; Sano H; Kanno T
    Neurosci Lett; 2007 Apr; 417(1):30-5. PubMed ID: 17398005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro selection of RNase P ribozymes that efficiently cleave a target mRNA.
    Kim K; Liu F
    Methods Mol Biol; 2004; 252():399-412. PubMed ID: 15017066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A minimised hammerhead ribozyme with activity against interleukin-2 in human cells.
    Sioud M; Opstad A; Hendry P; Lockett TJ; Jennings PA; McCall MJ
    Biochem Biophys Res Commun; 1997 Feb; 231(2):397-402. PubMed ID: 9070287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro construction of effective M1GS ribozymes targeting HCMV UL54 RNA segments.
    Su YZ; Li HJ; Li YQ; Chen HJ; Tang DS; Zhang X; Jiang H; Zhou TH
    Acta Biochim Biophys Sin (Shanghai); 2005 Mar; 37(3):210-4. PubMed ID: 15756425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.